RedHill Biopharma (RDHL) Change in Account Payables (2016 - 2022)
Historic Change in Account Payables for RedHill Biopharma (RDHL) over the last 7 years, with Q4 2022 value amounting to -$554000.0.
- RedHill Biopharma's Change in Account Payables rose 8452.95% to -$554000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was -$7.4 million, marking a year-over-year decrease of 679729.73%. This contributed to the annual value of -$2.1 million for FY2024, which is 12163.87% down from last year.
- Per RedHill Biopharma's latest filing, its Change in Account Payables stood at -$554000.0 for Q4 2022, which was up 8452.95% from $411000.0 recorded in Q3 2022.
- RedHill Biopharma's Change in Account Payables' 5-year high stood at $6.8 million during Q2 2021, with a 5-year trough of -$6.0 million in Q1 2022.
- In the last 5 years, RedHill Biopharma's Change in Account Payables had a median value of -$52500.0 in 2018 and averaged -$28750.0.
- In the last 5 years, RedHill Biopharma's Change in Account Payables tumbled by 523589.74% in 2018 and then surged by 237254.9% in 2020.
- Quarter analysis of 5 years shows RedHill Biopharma's Change in Account Payables stood at -$543000.0 in 2018, then fell by 12.34% to -$610000.0 in 2019, then soared by 917.05% to $5.0 million in 2020, then crashed by 171.85% to -$3.6 million in 2021, then soared by 84.53% to -$554000.0 in 2022.
- Its Change in Account Payables was -$554000.0 in Q4 2022, compared to $411000.0 in Q3 2022 and -$1.3 million in Q2 2022.